SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1
Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7418-7433
DOI: 10.1016/j.apsb.2026.07.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Liubing Du und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Commission of the People's Republic of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- The Division of Basic Research, Guangzhou National Laboratory, Bio-island, Guangzhou 510320, China.
- The Center for Infection and Immunity Study, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Förderung
- National Health Commission of the People's Republic of China
Zitieren
APA
Du, L., Wang, M., Liu, X., Peng, Z., Zhang, Z., Zhang, Z., Liang, Z., Sun, Q., Zhuang, J., Ma, K., Chen, Y. Q., Hou, P., Zhang, H., Guo, D., Pan, J. A., & Peng, X. (2026). SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1. Acta Pharmaceutica Sinica B, 16(11), 7418-7433. https://doi.org/10.1016/j.apsb.2026.07.042
Vancouver
Du L, Wang M, Liu X, Peng Z, Zhang Z, Zhang Z, et al. SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1. Acta Pharmaceutica Sinica B. 2026;16(11):7418-7433. doi:10.1016/j.apsb.2026.07.042
BibTeX
@article{Du2026,
author = {Du, Liubing and Wang, Mengxuan and Liu, Xue and Peng, Ziliang and Zhang, Zhihui and Zhang, Zhanjia and Liang, Zhijuan and Sun, Qingrong and Zhuang, Jiaxin and Ma, Kongyang and Chen, Yao-Qing and Hou, Panpan and Zhang, Hua and Guo, Deyin and Pan, Ji-An and Peng, Xiaoxue},
title = {SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {11},
pages = {7418--7433},
doi = {10.1016/j.apsb.2026.07.042}
}
EUVIMED